Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05535166 |
| Consolidated Lead Sponsor | St. Jude Children's Research Hospital |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 130 participants (ESTIMATED) |
| Registered Start Date | 2022-12-20 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Stanford Health Care and Stanford Cancer Institute | Stanford, CA | Open Hospital Dossier -> |
| University of Michigan Rogel Cancer Center | Ann Arbor, MI | Open Hospital Dossier -> |
| St. Jude Children's Research Hospital | Memphis, TN | Open Hospital Dossier -> |
| UT Southwestern Simmons Cancer Center | Dallas, TX | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for St. Jude Children's Research Hospital across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.